HAE
Haemonetics Corp
Price:  
70.09 
USD
Volume:  
289,017.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HAE Relative Valuation

36.5%
Upside

As of 2025-06-16, the Relative Valuation of Haemonetics Corp (HAE) is 95.69 USD. This relative valuation is based on P/E multiples. With the latest stock price at 70.09 USD, the upside of Haemonetics Corp based on Relative Valuation is 36.5%.

The range of the Relative Valuation is 70.16 - 122.86 USD.

Range Selected
Trailing P/E multiples 21.2x - 35.2x 28.2x
Forward P/E multiples 18.0x - 29.7x 23.8x
Fair Price 70.16 - 122.86 95.69
Upside 0.1% - 75.3% 36.5%
70.09 USD
Stock Price
95.69 USD
Fair Price

HAE Relative Valuation - Historical P/E Data

Date P/E
2025-06-13 20.08
2025-06-12 20.44
2025-06-11 20.49
2025-06-10 20.67
2025-06-09 20.53
2025-06-06 20.19
2025-06-05 20.17
2025-06-04 19.96
2025-06-03 19.96
2025-06-02 19.71
2025-05-30 19.40
2025-05-29 19.44
2025-05-28 19.37
2025-05-27 19.48
2025-05-23 18.93
2025-05-22 18.95
2025-05-21 19.17
2025-05-20 19.74
2025-05-19 19.87
2025-05-16 20.14
2025-05-15 19.88
2025-05-14 19.67
2025-05-13 19.81
2025-05-12 20.12
2025-05-09 19.54
2025-05-08 19.48
2025-05-07 18.41
2025-05-06 18.22
2025-05-05 17.90
2025-05-02 18.29
2025-05-01 18.05
2025-04-30 18.06
2025-04-29 18.33
2025-04-28 17.95
2025-04-25 17.91
2025-04-24 17.74
2025-04-23 17.29
2025-04-22 16.95
2025-04-21 16.33
2025-04-17 16.38
2025-04-16 16.30
2025-04-15 16.70
2025-04-14 17.02
2025-04-11 17.20
2025-04-10 16.98
2025-04-09 17.49
2025-04-08 16.06
2025-04-07 16.89
2025-04-04 17.44
2025-04-03 17.83